About the Company
We do not have any company description for Invivyd, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Invivyd, Inc.
Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates
Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.4 per share a year ago. These figures are ...
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-yearInvivyd’s target of near-term profitability (1H 2025) was not met but remains ...
Invivyd, Inc. (IVVD) Q2 2024 Earnings Call Transcript
Invivyd, Inc. (NASDAQ:IVVD) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ETCompany ParticipantsKatie Falzone - VP, Corporate ControllerMarc Elia ...
Invivyd Aligns with FDA for Rapid Approval Pathway
Invivyd ( ($IVVD) ) just unveiled an update. On August 14, 2025, Invivyd announced its alignment with the U.S. FDA on a rapid pathway to full ...
Invivyd, Inc. to Host Conference Call on May 15, 2025, to ... - Nasdaq
Invivyd, Inc., a biopharmaceutical company focused on developing treatments for serious viral infectious diseases, has announced a conference call on May 15, 2025, at 8:30 a.m. ET to discuss its ...
Invivyd, Inc. Reports Positive In Vitro Neutralization Data for ...
Invivyd, Inc. Reports Positive In Vitro Neutralization Data for PEMGARDA™ Against Dominant SARS-CoV-2 Variant LP.8.1 March 05, 2025 — 07:11 am EST Written by None for Quiver Quantitative -> ...
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025
Invivyd, Inc. (NASDAQ:IVVD) is up 179.85% year-to-date. Overall IVVD ranks 1st on our list of the biotech stocks that are skyrocketing so far in 2025.
Why Invivyd, Inc. (IVVD) Is Among the Best Penny Stocks to Invest In ...
In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against other best penny stocks to buy according to the media. Small-Cap Stocks Outlook for 2025 ...
Invivyd Elects Two New Independent Members to its Board of Directors
About Invivyd Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2.
Why Is COVID-19 Antibody Focused Invivyd Stock ... - Markets Insider
Invivyd Inc (NASDAQ: IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life ...
Invivyd, Inc. (IVVD) Q2 2023 Earnings Call Transcript
Invivyd, Inc. (NASDAQ:IVVD) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsGabriella Linville-Engler - Investor ...
Similar Companies
Loading the latest forecasts...